FDA announces voluntary tetracycline recall

The Food and Drug Administration recently announced that Avet Pharmaceuticals Inc. issued a voluntary recall of the antibiotic, tetracycline, specifically, Tetracycline HCl Capsules USP, 250 mg and 500 mg, distributed under the Heritage Pharmaceuticals Inc. label.

The drug maker reports that the affected products experience a low dissolution, resulting in less tetracycline in the body to combat infection. As a result, patients with compromised immune systems and the elderly, who may be taking tetracycline to treat a serious infection such as pneumonia, may experience rapid progression of infections or death.